[
  {
    "ts": "2026-02-05T02:07:57+00:00",
    "headline": "Dow Jones Futures: Google Beats Views, Huge AI Spending Stuns",
    "summary": "The rotation out of techs continued in a divided stock market, but Eli Lilly jumped. Google rose late on earnings and huge capital spending plans.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-falling-eli-lilly-soars-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
      "content": {
        "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
        "contentType": "STORY",
        "title": "Dow Jones Futures: Google Beats Views, Huge AI Spending Stuns",
        "description": "",
        "summary": "The rotation out of techs continued in a divided stock market, but Eli Lilly jumped. Google rose late on earnings and huge capital spending plans.",
        "pubDate": "2026-02-05T02:07:57Z",
        "displayTime": "2026-02-05T02:07:57Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/677bdc22-05ed-3320-ac7a-79b8c08a86d0/dow-jones-futures-google.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L4l8MOhcHp7duSBQOsJEMQ--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UPNT3tjMLQLXH6GEUSs.Jg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-falling-eli-lilly-soars-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "BE"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "CRUS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T04:05:55+00:00",
    "headline": "Dow Jones Futures Fall; Google Beats Views, Huge AI Spending Stuns",
    "summary": "The rotation out of techs continued in a divided stock market, but Eli Lilly jumped. Google rose late on earnings and huge capital spending plans.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-falling-eli-lilly-soars-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
      "content": {
        "id": "677bdc22-05ed-3320-ac7a-79b8c08a86d0",
        "contentType": "STORY",
        "title": "Dow Jones Futures Fall; Google Beats Views, Huge AI Spending Stuns",
        "description": "",
        "summary": "The rotation out of techs continued in a divided stock market, but Eli Lilly jumped. Google rose late on earnings and huge capital spending plans.",
        "pubDate": "2026-02-05T04:05:55Z",
        "displayTime": "2026-02-05T04:05:55Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/677bdc22-05ed-3320-ac7a-79b8c08a86d0/dow-jones-futures-fall-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967",
          "originalWidth": 1012,
          "originalHeight": 572,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L4l8MOhcHp7duSBQOsJEMQ--~B/aD01NzI7dz0xMDEyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 1012,
              "height": 572,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UPNT3tjMLQLXH6GEUSs.Jg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/2dc23d177054799afd413b73b997d967.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-futures-techs-falling-eli-lilly-soars-google-earnings-capital-spending/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMD"
            },
            {
              "symbol": "BE"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "CRUS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T03:38:34+00:00",
    "headline": "Why Eli Lilly Stock Soared Today",
    "summary": "The healthcare giant gained nearly $100 billion in market value.",
    "url": "https://www.fool.com/investing/2026/02/04/why-eli-lilly-stock-is-up-today/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "47a77f00-e8e8-3502-af6a-4f0458922b24",
      "content": {
        "id": "47a77f00-e8e8-3502-af6a-4f0458922b24",
        "contentType": "STORY",
        "title": "Why Eli Lilly Stock Soared Today",
        "description": "",
        "summary": "The healthcare giant gained nearly $100 billion in market value.",
        "pubDate": "2026-02-05T03:38:34Z",
        "displayTime": "2026-02-05T03:38:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b792e1f49374dc8f1f2a872f5210122e",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "A healthcare professional is looking at medical supplies. ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iohU2ON1aFYggmt2nhe9MA--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b792e1f49374dc8f1f2a872f5210122e.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Gq5fA0kI1RXhS4uCxWmmqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b792e1f49374dc8f1f2a872f5210122e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/04/why-eli-lilly-stock-is-up-today/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-eli-lilly-stock-soared-033834668.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T04:37:01+00:00",
    "headline": "Is Eli Lilly (LLY) Still Attractive After Obesity Drug Headlines And A US$1,107 Share Price?",
    "summary": "If you are wondering whether Eli Lilly's share price already reflects what you are hearing about weight loss and other treatments, or if there could still be value on the table, this article walks through what the numbers are saying right now. The stock last closed at US$1,107.12, with returns of 8.1% over 7 days, 6.3% over 30 days, 2.5% year to date, 32.4% over 1 year, and a very large gain over 5 years. Recent headlines have focused heavily on Eli Lilly's obesity and diabetes drug...",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-attractive-043701975.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "76eec517-69b3-3a03-a8f0-60e06a0a38eb",
      "content": {
        "id": "76eec517-69b3-3a03-a8f0-60e06a0a38eb",
        "contentType": "STORY",
        "title": "Is Eli Lilly (LLY) Still Attractive After Obesity Drug Headlines And A US$1,107 Share Price?",
        "description": "",
        "summary": "If you are wondering whether Eli Lilly's share price already reflects what you are hearing about weight loss and other treatments, or if there could still be value on the table, this article walks through what the numbers are saying right now. The stock last closed at US$1,107.12, with returns of 8.1% over 7 days, 6.3% over 30 days, 2.5% year to date, 32.4% over 1 year, and a very large gain over 5 years. Recent headlines have focused heavily on Eli Lilly's obesity and diabetes drug...",
        "pubDate": "2026-02-05T04:37:01Z",
        "displayTime": "2026-02-05T04:37:01Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-attractive-043701975.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-still-attractive-043701975.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T08:26:58+00:00",
    "headline": "Eli Lilly and Company Q4 Earnings Call Highlights",
    "summary": "Eli Lilly and Company (NYSE:LLY) executives highlighted strong 2025 performance, continued demand for its incretin medicines, and an expanding late-stage pipeline during the company’s Q4 2025 earnings conference call. Management also outlined 2026 financial guidance that anticipates higher revenue d",
    "url": "https://www.marketbeat.com/instant-alerts/eli-lilly-and-company-q4-earnings-call-highlights-2026-02-05/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "6da620fb-a60b-3ff9-a156-46499365355f",
      "content": {
        "id": "6da620fb-a60b-3ff9-a156-46499365355f",
        "contentType": "STORY",
        "title": "Eli Lilly and Company Q4 Earnings Call Highlights",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE:LLY) executives highlighted strong 2025 performance, continued demand for its incretin medicines, and an expanding late-stage pipeline during the company’s Q4 2025 earnings conference call. Management also outlined 2026 financial guidance that anticipates higher revenue d",
        "pubDate": "2026-02-05T08:26:58Z",
        "displayTime": "2026-02-05T08:26:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/4896a73d5f97078f97737a29264eae52",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Eli Lilly and Company logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZBike2mUCJL3A7TJ3j5YfA--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/4896a73d5f97078f97737a29264eae52.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xwWXBJrcUH6CNcgB4DM1DQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/4896a73d5f97078f97737a29264eae52.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/instant-alerts/eli-lilly-and-company-q4-earnings-call-highlights-2026-02-05/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-company-q4-earnings-082658839.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-05T07:28:24+00:00",
    "headline": "Eli Lilly (LLY) Skyrockets as Profits Soar 95%",
    "summary": "We recently published 10 Stocks With Monster Gains. Eli Lilly and Company (NYSE:LLY) was one of the top performers on Wednesday. Eli Lilly soared by 10.33 percent on Wednesday to close at $1,107.12 apiece after profits last year nearly doubled on the back of strong sales from Zepbound and Mounjaro, alongside a 23 percent revenue […]",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-skyrockets-profits-072824114.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "24a1d120-1296-3308-8708-da9d13554ce6",
      "content": {
        "id": "24a1d120-1296-3308-8708-da9d13554ce6",
        "contentType": "STORY",
        "title": "Eli Lilly (LLY) Skyrockets as Profits Soar 95%",
        "description": "",
        "summary": "We recently published 10 Stocks With Monster Gains. Eli Lilly and Company (NYSE:LLY) was one of the top performers on Wednesday. Eli Lilly soared by 10.33 percent on Wednesday to close at $1,107.12 apiece after profits last year nearly doubled on the back of strong sales from Zepbound and Mounjaro, alongside a 23 percent revenue […]",
        "pubDate": "2026-02-05T07:28:24Z",
        "displayTime": "2026-02-05T07:28:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d",
          "originalWidth": 1280,
          "originalHeight": 853,
          "caption": "Eli Lilly (LLY) Skyrockets as Profits Soar 95%",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OdUZhzJneaC3psvAqDZt0Q--~B/aD04NTM7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d.cf.webp",
              "width": 1280,
              "height": 853,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/igPuOk294DrUoWTvXb9e3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f4f6ab0951c1038aa2303274fb6c0b9d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-skyrockets-profits-072824114.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-skyrockets-profits-072824114.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]